{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:05:54Z","timestamp":1655402754573},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10620-014-3510-y","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T10:19:51Z","timestamp":1423045191000},"page":"1755-1760","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["No Association Between Serum Adenosine Deaminase Activity and Disease Activity in Crohn\u2019s Disease"],"prefix":"10.1007","volume":"60","author":[{"given":"Mahmoud","family":"Sajjadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Gholamrezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser Ebrahimi","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"3510_CR1","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066\u20132078.","journal-title":"N Engl J Med"},{"key":"3510_CR2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2007.09.001","volume":"133","author":"S Nikolaus","year":"2007","unstructured":"Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670\u20131689.","journal-title":"Gastroenterology"},{"key":"3510_CR3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.2010.224154","volume":"60","author":"C Mowat","year":"2011","unstructured":"Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571\u2013607.","journal-title":"Gut"},{"key":"3510_CR4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/gut.2005.069476","volume":"55","author":"S Vermeire","year":"2006","unstructured":"Vermeire S, Van AG, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426\u2013431.","journal-title":"Gut"},{"key":"3510_CR5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","volume":"70","author":"WR Best","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn\u2019s disease activity index. National Cooperative Crohn\u2019s Disease Study. Gastroenterology. 1976;70:439\u2013444.","journal-title":"Gastroenterology"},{"key":"3510_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","volume":"43","author":"RS Walmsley","year":"1998","unstructured":"Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43:29\u201332.","journal-title":"Gut"},{"key":"3510_CR7","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/ibd.20178","volume":"13","author":"MA Denis","year":"2007","unstructured":"Denis MA, Reenaers C, Fontaine F, et al. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn\u2019s disease with normal C-reactive protein serum level. Inflamm Bowel Dis. 2007;13:1100\u20131105.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ibd.20312","volume":"14","author":"T Sipponen","year":"2008","unstructured":"Sipponen T, Savilahti E, Kolho KL, et al. Crohn\u2019s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn\u2019s disease activity index and endoscopic findings. Inflamm Bowel Dis. 2008;14:40\u201346.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR9","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/ibd.20509","volume":"14","author":"A Efthymiou","year":"2008","unstructured":"Efthymiou A, Viazis N, Mantzaris G, et al. Does clinical response correlate with mucosal healing in patients with Crohn\u2019s disease of the small bowel? A prospective, case-series study using wireless capsule endoscopy. Inflamm Bowel Dis. 2008;14:1542\u20131547.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/ibd.21355","volume":"17","author":"M Regueiro","year":"2011","unstructured":"Regueiro M, Kip KE, Schraut W, et al. Crohn\u2019s disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection. Inflamm Bowel Dis. 2011;17:118\u2013126.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR11","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ibd.20986","volume":"15","author":"AM Schoepfer","year":"2009","unstructured":"Schoepfer AM, Beglinger C, Straumann A, et al. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis. 2009;15:1851\u20131858.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","volume":"105","author":"AM Schoepfer","year":"2010","unstructured":"Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn\u2019s disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am J Gastroenterol. 2010;105:162\u2013169.","journal-title":"Am J Gastroenterol"},{"key":"3510_CR13","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/ibd.22896","volume":"18","author":"PF Rheenen van","year":"2012","unstructured":"van Rheenen PF. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control. Inflamm Bowel Dis. 2012;18:2018\u20132025.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MIB.0b013e3182810066","volume":"19","author":"AM Schoepfer","year":"2013","unstructured":"Schoepfer AM, Beglinger C, Straumann A, et al. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes. Inflamm Bowel Dis. 2013;19:332\u2013341.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1542-3565(04)00441-0","volume":"3","author":"DS Fefferman","year":"2005","unstructured":"Fefferman DS, Farrell RJ. Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice. Clin Gastroenterol Hepatol. 2005;3:11\u201324.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3510_CR16","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MIB.0000442681.85545.31","volume":"20","author":"U Kopylov","year":"2014","unstructured":"Kopylov U, Rosenfeld G, Bressler B, et al. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:742\u2013756.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/MIB.0000000000000057","volume":"20","author":"JF Lin","year":"2014","unstructured":"Lin JF, Chen JM, Zuo JH, et al. Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity. Inflamm Bowel Dis. 2014;20:1407\u20131415.","journal-title":"Inflamm Bowel Dis"},{"key":"3510_CR18","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/ajg.2010.292","volume":"105","author":"J Keohane","year":"2010","unstructured":"Keohane J, O\u2019Mahony C, O\u2019Mahony L, et al. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010;105:1788\u20131794.","journal-title":"Am J Gastroenterol"},{"key":"3510_CR19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2174\/138945012800564095","volume":"13","author":"L Antonioli","year":"2012","unstructured":"Antonioli L, Colucci R, La MC, et al. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets. 2012;13:842\u2013862.","journal-title":"Curr Drug Targets"},{"key":"3510_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/jappl.1994.76.1.5","volume":"76","author":"BN Cronstein","year":"1994","unstructured":"Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 1994;76:5\u201313.","journal-title":"J Appl Physiol"},{"key":"3510_CR21","first-page":"87","volume":"21","author":"RA Sari","year":"2003","unstructured":"Sari RA, Taysi S, Yilmaz O, et al. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2003;21:87\u201390.","journal-title":"Clin Exp Rheumatol"},{"key":"3510_CR22","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00296-011-1836-8","volume":"32","author":"R Saghiri","year":"2012","unstructured":"Saghiri R, Ghashghai N, Movaseghi S, et al. Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern. Rheumatol Int. 2012;32:1633\u20131638.","journal-title":"Rheumatol Int"},{"key":"3510_CR23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcla.20410","volume":"24","author":"B Cakal","year":"2010","unstructured":"Cakal B, Beyazit Y, Koklu S, et al. Elevated adenosine deaminase levels in celiac disease. J Clin Lab Anal. 2010;24:323\u2013326.","journal-title":"J Clin Lab Anal"},{"key":"3510_CR24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1159\/000108970","volume":"7","author":"M Ibis","year":"2007","unstructured":"Ibis M, Koklu S, Yilmaz FM, et al. Serum adenosine deaminase levels in pancreatic diseases. Pancreatology. 2007;7:526\u2013530.","journal-title":"Pancreatology"},{"key":"3510_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s100670170005","volume":"20","author":"S Hitoglou","year":"2001","unstructured":"Hitoglou S, Hatzistilianou M, Gougoustamou D, et al. Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2001;20:411\u2013416.","journal-title":"Clin Rheumatol"},{"key":"3510_CR26","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MEG.0b013e328346e205","volume":"23","author":"I Maor","year":"2011","unstructured":"Maor I, Rainis T, Lanir A, et al. Adenosine deaminase activity in patients with Crohn\u2019s disease: distinction between active and nonactive disease. Eur J Gastroenterol Hepatol. 2011;23:598\u2013602.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3510_CR27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.crohns.2011.07.010","volume":"6","author":"Y Beyazit","year":"2012","unstructured":"Beyazit Y, Koklu S, Tas A, et al. Serum adenosine deaminase activity as a predictor of disease severity in ulcerative colitis. J Crohns Colitis. 2012;6:102\u2013107.","journal-title":"J Crohns Colitis"},{"key":"3510_CR28","first-page":"315","volume-title":"Methods of enzymatic analysis","author":"G Giusti","year":"1984","unstructured":"Giusti G, Galanti B. Colorimetric method. In: Bergmeyer HU, ed. Methods of enzymatic analysis. Weinheim: Verlag Chemie; 1984:315\u2013323."},{"key":"3510_CR29","doi-asserted-by":"crossref","unstructured":"Daperno M, Castiglione F, de Ridder L, et al. Results of the 2nd part Scientific Workshop of the ECCO. II: measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease. J Crohns Colitis. 2011;5:484\u2013498.","DOI":"10.1016\/j.crohns.2011.07.003"},{"key":"3510_CR30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.crohns.2011.09.008","volume":"6","author":"AM Schoepfer","year":"2012","unstructured":"Schoepfer AM, Vavricka S, Zahnd-Straumann N, et al. Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers. J Crohns Colitis.. 2012;6:412\u2013418.","journal-title":"J Crohns Colitis."},{"key":"3510_CR31","doi-asserted-by":"crossref","first-page":"c3369","DOI":"10.1136\/bmj.c3369","volume":"341","author":"PF Rheenen van","year":"2010","unstructured":"van Rheenen PF. Van d, V, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;341:c3369.","journal-title":"BMJ"},{"key":"3510_CR32","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","volume":"140","author":"JD Lewis","year":"2011","unstructured":"Lewis JD. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 2011;140:1817\u20131826.","journal-title":"Gastroenterology"},{"key":"3510_CR33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2012.01.007","volume":"41","author":"BP Abraham","year":"2012","unstructured":"Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012;41:483\u2013495.","journal-title":"Gastroenterol Clin North Am"},{"key":"3510_CR34","doi-asserted-by":"crossref","unstructured":"Waugh N, Cummins E, Royle P, et al. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation. Health Technol Assess. 2013;17:xv\u2013xix, 1\u2013211.","DOI":"10.3310\/hta17550"},{"key":"3510_CR35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09629350123332","volume":"10","author":"TS Frode","year":"2001","unstructured":"Frode TS, Medeiros YS. Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm. 2001;10:223\u2013227.","journal-title":"Mediators Inflamm"},{"key":"3510_CR36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1189\/jlb.1109764","volume":"88","author":"AV Zavialov","year":"2010","unstructured":"Zavialov AV, Gracia E, Glaichenhaus N, et al. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88:279\u2013290.","journal-title":"J Leukoc Biol"},{"key":"3510_CR37","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s00296-011-1912-0","volume":"32","author":"B Zamani","year":"2012","unstructured":"Zamani B, Jamali R, Jamali A. Serum adenosine deaminase may predict disease activity in rheumatoid arthritis. Rheumatol Int. 2012;32:1967\u20131975.","journal-title":"Rheumatol Int"},{"key":"3510_CR38","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3748\/wjg.15.4491","volume":"15","author":"JH Ye","year":"2009","unstructured":"Ye JH, Rajendran VM. Adenosine: an immune modulator of inflammatory bowel diseases. World J Gastroenterol. 2009;15:4491\u20134498.","journal-title":"World J Gastroenterol"},{"key":"3510_CR39","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/jpet.107.122762","volume":"322","author":"L Antonioli","year":"2007","unstructured":"Antonioli L, Fornai M, Colucci R, et al. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther. 2007;322:435\u2013442.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3510-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-014-3510-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3510-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T16:17:45Z","timestamp":1566317865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-014-3510-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3510"],"URL":"https:\/\/doi.org\/10.1007\/s10620-014-3510-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}